- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/10 - Antimycotics
Patent holdings for IPC class A61P 31/10
Total number of patents in this class: 2484
10-year publication summary
93
|
81
|
90
|
151
|
201
|
194
|
228
|
179
|
205
|
126
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
King Faisal University | 409 |
83 |
Nihon Nohyaku Co., Ltd. | 313 |
24 |
Centre National de La Recherche Scientifique | 9632 |
22 |
Scynexis, Inc. | 69 |
22 |
POLA Pharma Inc. | 77 |
20 |
BASF SE | 19740 |
19 |
Eisai R&D Management Co., Ltd. | 1304 |
18 |
The Board of Trustees of the University of Illinois | 2623 |
17 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
17 |
Kaken Pharmaceutical Co., Ltd. | 97 |
15 |
Cidara Therapeutics, Inc. | 87 |
14 |
F2g Ltd | 44 |
14 |
Janssen Pharmaceutica N.V. | 3839 |
10 |
Board of Regents, The University of Texas System | 5370 |
10 |
The Brigham and Women's Hospital, Inc. | 2087 |
10 |
Toyama Chemical Co., Ltd. | 114 |
10 |
President and Fellows of Harvard College | 5792 |
9 |
Institut National de La Sante et de La Recherche Medicale (inserm) | 2360 |
9 |
Nippon Soda Co., Ltd. | 890 |
9 |
Novartis AG | 11238 |
8 |
Other owners | 2124 |